Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Nov 2025: France's competition authority fined Doctolib about EUR 4.67m for abusing a dominant position via exclusivity clauses, tied subscriptions and its 2018 MonDocteur acquisition; Doctolib denies being dominant and said it will appeal.
Data breaches, cyber incidents, regulator action and assurance status.
Jan 2026: patient data linked to two French providers appeared on a hacking forum; Doctolib said the leak did not come from its servers but from data the providers exported when leaving. Jul 2026: rights group LDH criticised its opt-out use of health data for AI research. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Booking, patient engagement and teleconsultation software supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract delivery, go-lives, terminations and disputes.
No notable go-lives, troubled implementations, terminations or customer disputes involving Doctolib found in HSH's search of the last 24 months.